INVESTIGATION OF ANTI-SARS COV-2 ACTIVITY OF SOME TETRAHYDRO CURCUMIN DERIVATIVES: AN IN SILICO STUDY
DOI:
https://doi.org/10.22159/ijap.2023v15i1.46288Keywords:
THC derivatives, Covid-19, SARS CoV 2, Main protease (MPro), Molecular dockingAbstract
Objective: In the current study, an in silico approach has been utilized to investigate the anti-SARS CoV 2 activity of some derivatives of Tetrahydro curcumin (THC), a curcumin metabolite.
Methods: BioVia Draw 2017 was used to design 168 THC derivatives. All of the derivatives were docked using Maestro Schrodinger programme. Depending on the docking score, the ADME, drug-likeness, and toxicity prediction of a few THC derivatives were conducted.
Results: 168 THC derivatives were designed. 14 derivatives exhibited a better binding score than Remdesivir. All 14 derivatives' pharmacokinetic characteristics were discovered to be within the acceptable range. Lipinski's rule of five was violated by all derivatives, including the reference drug, yet they all stayed within the recommended range. The greatest docking score among the 14 derivatives was displayed by Structure 21. A study on molecular dynamic (MD) stimulation showed that the protein-ligand complex was relatively stable. Toxicity prediction showed that 14 derivatives were non-hepatotoxic, non-cytotoxic, immunotoxic (except S21), non-mutagenic (except S31) and half of the developed structures were carcinogenic, while the other half, including the standard drug, was non-carcinogenic.
Conclusion: Among 168 THC derivatives, 14 derivatives exhibited better binding score than the reference drug. For all 14 derivatives, pharmacokinetic, drug-likeness, and toxicity prediction were found to be satisfactory. It was discovered that the protein-ligand complex was thermodynamically stable. All 14 compounds present exciting prospects for further in vitro and in vivo investigation.
Downloads
References
Mohan BS, Nambiar V. COVID-19: an insight into SARS-CoV-2 pandemic originated at Wuhan City in Hubei Province of China. J Infect Dis Epidemiol. 2020 Jul 18;6(4):146.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020 Mar 19;91(1):157-60. doi: 10.23750/abm.v91i1.9397, PMID 32191675.
Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020 Mar 26;12(3):e7423. doi: 10.7759/cureus.7423, PMID 32337143.
Mengist HM, Dilnessa T, Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front Chem. 2021 Mar 12;9:622898. doi: 10.3389/fchem.2021.622898, PMID 33889562.
Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878. doi: 10.1016/j.bbadis.2020.165878, PMID 32544429.
Forni G, Mantovani A, COVID-19 commission of accademia nazionale dei lincei, rome. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021 Jan 21;28(2):626-39. doi: 10.1038/s41418-020-00720-9, PMID 33479399.
Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jun 1;19(7):409-24.
Lai CS, Ho CT, Pan MH. The cancer chemopreventive and therapeutic potential of tetrahydrocurcumin. Biomolecules. 2020 May 29;10(6):831. doi: 10.3390/biom10060831, PMID 32486019.
Aggarwal BB, Deb L, Prasad S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules. 2014 Dec 24;20(1):185-205. doi: 10.3390/molecules20010185, PMID 25547723.
Chen X, Li H, Tian L, Li Q, Luo J, Zhang Y. Analysis of the physicochemical properties of acaricides based on Lipinski’s rule of five. J Comput Biol. 2020 Sep 1;27(9):1397-406. doi: 10.1089/cmb.2019.0323, PMID 32031890.
Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a web server for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018 Jul 2;46(W1):W257-63. doi: 10.1093/nar/gky318, PMID 29718510.
Nazwir N, Yanuar A, Syahdi RR. In silico investigation of Echinodermata secondary metabolites as human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors. Int J App Pharm. 2020 Mar 23;12(1):51-5. doi: 10.22159/ijap.2020.v12s1.FF006.
Vasava MS, Bhoi MN, Rathwa SK, Shetty SS, Patel RD, Rajani DP. Novel 1, 4-dihydropyrano [2, 3-c] pyrazole derivatives: synthesis, characterization, biological evaluation and in silico study. J Mol Struct. 2019 Apr 5;1181:383-402.
Muttaqin FZ, Fakih TM, Muhammad HN. Molecular docking, molecular dynamics, and in silico toxicity prediction studies of coumarin, n-oxalylglycine, organoselenium, organosulfur, and pyridine derivatives as histone lysine demethylase inhibitors. Asian J Pharm Clin Res. 2017;10(12):212-5. doi: 10.22159/ajpcr.2017.v10i12.19348.
Fan J, Fu A, Zhang L. Progress in molecular docking. Quant Biol. 2019 Jun;7(2):83-9. doi: 10.1007/s40484-019-0172-y.
Pagadala NS, Syed K, Tuszynski J. Software for molecular docking: a review. Biophys Rev. 2017 Jan 16;9(2):91-102. doi: 10.1007/s12551-016-0247-1, PMID 28510083.
Bhavsar ZA, Acharya PT, Jethava DJ, Patel DB, Vasava MS, Rajani DP. Microwave-assisted synthesis, biological activities, and in silico investigation of some benzimidazole derivatives. J Heterocyclic Chem. 2020 Dec;57(12):4215-38. doi: 10.1002/jhet.4129.
Vieira DS, Degrève L. An insight into the thermostability of a pair of xylanases: the role of hydrogen bonds. Mol Phys. 2009 Jan 10;107(1):59-69. doi: 10.1080/00268970902717959.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr. Mahesh Vasava, AMRITA MURALIKRISHNAN, JASMIN KUBAVAT, SRIKANTH JUPUDI, NAMITHA BIJU
This work is licensed under a Creative Commons Attribution 4.0 International License.
